Your browser doesn't support javascript.
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Dejnirattisai, Wanwisa; Shaw, Robert H; Supasa, Piyada; Liu, Chang; Stuart, Arabella Sv; Pollard, Andrew J; Liu, Xinxue; Lambe, Teresa; Crook, Derrick; Stuart, Dave I; Mongkolsapaya, Juthathip; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Screaton, Gavin R.
  • Dejnirattisai W; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK.
  • Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Supasa P; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.
  • Liu C; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK.
  • Stuart AS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK.
  • Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Lambe T; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
  • Crook D; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK; Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.
  • Stuart DI; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Division of Structural Biology, University of Oxford, Oxford OX3 9DU, UK; Diamond Light Sourc
  • Mongkolsapaya J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK; Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Dean Office for Resea
  • Nguyen-Van-Tam JS; Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford OX3 9DU, UK. Electronic address: matthew.snape@paediatrics.ox.ac.uk.
  • Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK.
Lancet ; 399(10321): 234-236, 2022 01 15.
Artículo en Inglés | MEDLINE | ID: covidwho-1586213
Preprint
Este artículo de revista científica es probablemente basado en un preprint previamente disponible, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver preprint

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Revista: Lancet Año: 2022 Tipo del documento: Artículo País de afiliación: S0140-6736(21)02844-0

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Revista: Lancet Año: 2022 Tipo del documento: Artículo País de afiliación: S0140-6736(21)02844-0